AAAAAA

   
Results: 1-6 |
Results: 6
A RANDOMIZED INVESTIGATION OF HIGH-DOSE VERSUS STANDARD-DOSE CYTOSINE-ARABINOSIDE WITH DAUNORUBICIN IN PATIENTS WITH PREVIOUSLY UNTREATED ACUTE MYELOID-LEUKEMIA - A SOUTHWEST-ONCOLOGY-GROUP STUDY
Authors: WEICK JK KOPECKY KJ APPELBAUM FR HEAD DR KINGSBURY LL BALCERZAK SP BICKERS JN HYNES HE WELBORN JL SIMON SR GREVER M
Citation: Jk. Weick et al., A RANDOMIZED INVESTIGATION OF HIGH-DOSE VERSUS STANDARD-DOSE CYTOSINE-ARABINOSIDE WITH DAUNORUBICIN IN PATIENTS WITH PREVIOUSLY UNTREATED ACUTE MYELOID-LEUKEMIA - A SOUTHWEST-ONCOLOGY-GROUP STUDY, Blood, 88(8), 1996, pp. 2841-2851
CONCURRENT CISPLATIN ETOPOSIDE PLUS CHEST RADIOTHERAPY FOLLOWED BY SURGERY FOR STAGES IIIA(N2) AND IIIB NON-SMALL-CELL LUNG-CANCER - MATURERESULTS OF SOUTHWEST-ONCOLOGY-GROUP PHASE-II STUDY-8805/
Authors: ALBAIN KS RUSCH VW CROWLEY JJ RICE TW TURRISI AT WEICK JK LONCHYNA VA PRESANT CA MCKENNA RJ GANDARA DR FOSMIRE H TAYLOR SA STELZER KJ BEASLEY KR LIVINGSTON RB
Citation: Ks. Albain et al., CONCURRENT CISPLATIN ETOPOSIDE PLUS CHEST RADIOTHERAPY FOLLOWED BY SURGERY FOR STAGES IIIA(N2) AND IIIB NON-SMALL-CELL LUNG-CANCER - MATURERESULTS OF SOUTHWEST-ONCOLOGY-GROUP PHASE-II STUDY-8805/, Journal of clinical oncology, 13(8), 1995, pp. 1880-1892
CORRELATION OF MULTIDRUG-RESISTANCE (MDR1) PROTEIN EXPRESSION WITH FUNCTIONAL DYE DRUG EFFLUX IN ACUTE MYELOID-LEUKEMIA BY MULTIPARAMETER FLOW-CYTOMETRY - IDENTIFICATION OF DISCORDANT MDR(-)/EFFLUX(+) AND MDR1(+)/EFFLUX(-) CASES/
Authors: LEITH CP CHEN IM KOPECKY KJ APPELBAUM FR HEAD DR GODWIN JE WEICK JK WILLMAN CL
Citation: Cp. Leith et al., CORRELATION OF MULTIDRUG-RESISTANCE (MDR1) PROTEIN EXPRESSION WITH FUNCTIONAL DYE DRUG EFFLUX IN ACUTE MYELOID-LEUKEMIA BY MULTIPARAMETER FLOW-CYTOMETRY - IDENTIFICATION OF DISCORDANT MDR(-)/EFFLUX(+) AND MDR1(+)/EFFLUX(-) CASES/, Blood, 86(6), 1995, pp. 2329-2342
PHASE-II STUDY OF CARBOPLATIN (CBDCA) IN REFRACTORY MULTIPLE-MYELOMA
Authors: BARLOGIE B CROWLEY J SALMON SE BONNET J WEICK JK HAYDEN K
Citation: B. Barlogie et al., PHASE-II STUDY OF CARBOPLATIN (CBDCA) IN REFRACTORY MULTIPLE-MYELOMA, Investigational new drugs, 12(1), 1994, pp. 53-55
AGGRESSIVE MULTIMODALITY THERAPY FOR MALIGNANT PLEURAL MESOTHELIOMA
Authors: RICE TW ADELSTEIN DJ KIRBY TJ SALTARELLI MG MURTHY SR VANKIRK MA WIEDEMANN HP WEICK JK
Citation: Tw. Rice et al., AGGRESSIVE MULTIMODALITY THERAPY FOR MALIGNANT PLEURAL MESOTHELIOMA, The Annals of thoracic surgery, 58(1), 1994, pp. 24-29
EXTENDED ADMINISTRATION OF ORAL ETOPOSIDE AND ORAL CYCLOPHOSPHAMIDE FOR THE TREATMENT OF ADVANCED NON-SMALL-CELL LUNG-CANCER - A SOUTHWEST-ONCOLOGY-GROUP STUDY
Authors: GRUNBERG SM CROWLEY J LIVINGSTON R GILL I WILLIAMSON SK OROURKE T BRAUN T MARSHALL ME WEICK JK BALCERZAK SP MARTINO RL
Citation: Sm. Grunberg et al., EXTENDED ADMINISTRATION OF ORAL ETOPOSIDE AND ORAL CYCLOPHOSPHAMIDE FOR THE TREATMENT OF ADVANCED NON-SMALL-CELL LUNG-CANCER - A SOUTHWEST-ONCOLOGY-GROUP STUDY, Journal of clinical oncology, 11(8), 1993, pp. 1598-1601
Risultati: 1-6 |